Gemcitabine and platinum combinations in pancreatic cancer

This publication has 11 references indexed in Scilit:

• Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma
  Cancer, 2001
• Definitive Results of a Phase II Trial of Cisplatin, Epirubicin, Continuous-Infusion Fluorouracil, and Gemcitabine in Stage IV Pancreatic Adenocarcinoma
  Journal of Clinical Oncology, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
  Annals of Oncology, 2000
• Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
  Anti-Cancer Drugs, 2000
• Supraadditive effect of 2 ′ ,2 ′ -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
  Cancer Chemotherapy and Pharmacology, 1999
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
  Journal of Clinical Oncology, 1997
• Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
  Investigational New Drugs, 1994
• Activity of cisplatin in adenocarcinoma of the pancreas
  European Journal Of Cancer, 1993
• Prognostic indicators for survival after resection of pancreatic adenocarcinoma
  The American Journal of Surgery, 1993